Women's Health Research Program, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
ANZAC Research Institute, University of Sydney, Sydney, New South Wales, Australia.
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5382-5392. doi: 10.1210/jc.2019-01357.
Whether serum androgen levels can identify women with "androgen insufficiency" or "androgen excess" is unresolved; thus, what constitutes "normal" remains uncertain. We sought to determine whether androgens, including 11-oxygenated C19 steroids, vary with age, menstrual cycle, or body mass index (BMI), during the reproductive years.
Cross-sectional study recruited from eastern Australian states.
A total of 588 women, aged 18 to 39 years, who were not pregnant, lactating, or using systemic hormone therapy, with regular menstrual cycles and no previous diagnosis of polycystic ovarian syndrome.
Sex steroids measured using liquid chromatography-tandem mass spectrometry.
Testosterone and androstenedione concentrations were significantly higher during the menstrual cycle mid- and luteal phases than in the early follicular phase, with median values across the cycle of 0.34 nmol/L (range, 0.04 to 1.01) and 1.97 nmol/L (range, 0.53 to 7.89), respectively. No cyclical variations were found in dehydroepiandrosterone (DHEA; 4.91 nmol/L; range, 0.08 to 23.51), 11-ketoandrostenedione (11KA; 7.99 nmol/L; range, 0.07 to 31.67), or 11-ketotestosterone (11KT; 1.27 nmol/L; range, 0.03 to 7.61). Overweight women had lower median testosterone (P < 0.05), DHEA (P < 0.05), and 11KA (P < 0.01) levels than normal-weight women. All C19 steroids were significantly lower (P < 0.01) in those aged 35 to 39 years than in those aged 18 to 25 years. The median 11KA/androstenedione (4.3:1) and 11KT/testosterone (3.9:1) ratios did not change with age, after adjustment for BMI and cycle stage.
We have demonstrated that 11KA and 11KT are stable across the menstrual cycle and make major quantitative contributions to the circulating androgen pool. All C19 androgens declined with age before menopause; hence, age-specific reference ranges are required for the interpretation of androgen levels in premenopausal women.
血清雄激素水平能否识别出具有“雄激素不足”或“雄激素过多”的女性仍未得到解决;因此,“正常”的范围仍不确定。我们试图确定雄激素,包括 11-氧代 C19 类固醇,在生殖年龄期间是否会随年龄、月经周期或体重指数(BMI)而变化。
从澳大利亚东部各州招募的横断面研究。
共 588 名年龄在 18 至 39 岁之间、未怀孕、未哺乳或未使用全身激素治疗、月经周期规律且无多囊卵巢综合征既往诊断的女性。
使用液相色谱-串联质谱法测量性激素。
与卵泡早期相比,在月经周期的中期和黄体期,睾酮和雄烯二酮的浓度明显更高,整个周期的中位数分别为 0.34 nmol/L(范围为 0.04 至 1.01)和 1.97 nmol/L(范围为 0.53 至 7.89)。未发现脱氢表雄酮(DHEA;4.91 nmol/L;范围为 0.08 至 23.51)、11-酮雄烯二酮(11KA;7.99 nmol/L;范围为 0.07 至 31.67)或 11-酮睾酮(11KT;1.27 nmol/L;范围为 0.03 至 7.61)的周期性变化。超重女性的睾酮(P < 0.05)、DHEA(P < 0.05)和 11KA(P < 0.01)水平中位数低于正常体重女性。所有 C19 类固醇在 35 至 39 岁年龄组中的水平明显低于 18 至 25 岁年龄组(P < 0.01)。在调整 BMI 和周期阶段后,11KA/雄烯二酮(4.3:1)和 11KT/睾酮(3.9:1)比值的中位数均未随年龄变化。
我们已经证明 11KA 和 11KT 在月经周期内是稳定的,并且对循环雄激素池有重要的定量贡献。所有 C19 雄激素在绝经前都会随着年龄的增长而下降;因此,需要为绝经前妇女的雄激素水平提供年龄特异性参考范围。